RANTES Produced by Actiated Lymphocytes Costimulated by Anti-CD3 mAb and Anti-CD28 mAb

被引:0
|
作者
Gu, Xiao [1 ]
Tang, Xiao-Da [1 ]
Gu, Shen-Yang [2 ]
Yang, Shang-Qi [1 ]
Zhou, Pei-Jun [1 ]
Xu, Da [3 ]
Wang, Xiang-Hui [3 ]
Tan, Jian-Ming [1 ]
机构
[1] Clin. O. Transplant. Ctr. Shanghai, Shanghai First People's Hospital, Shanghai 200080, China
[2] Department of Urology, Clinical Medical College, Yangzhou University, Yangzhou 225001, China
[3] Department of Urology, Affil. Hosp. S. Med. Univ. Shanghai, Shanghai 200025, China
来源
Fudan University Journal of Medical Sciences | 2003年 / 30卷 / 06期
关键词
Cells - Patient monitoring;
D O I
暂无
中图分类号
学科分类号
摘要
Purpose: To investigate the changes of regulated upon activation, normal T cell expressed and secreted (RANTES) level produced by activated lymphocytes costimulated by CD28 pathway and the effects of Cyclosporin A(CsA). Methods: Human peripheral lymphocytes separated by Ficoll were divided into four groups: anti-CD3mAb group, anti-CD28mAb group, CD28 costimulation group and control group. CD28 costimulation group was treated by different concentrations of PDTC or CsA. RANTES levels were detected by ELISA and CD25 and CCR5 expression of lymphocytes were detected by FCM. Results: RANTES concentration was significantly higher in CD28 costimulation group than other group (P < 0.05). RANTES secreted by lymphocytes could be inhibited by PDTC or CsA. CD25 expression was upregulated after lymphocytes costimulated by CD28 pathway, on the contrary, CCR5 was significantly downregulated (P < 0.05). Conclusions: CD28 costimulating lymphocytes play a important role on RANTES generation which regulated by NF-κB pathway. Lymphocytes producing RANTES and their reaction to RANTES were both related to CD28 pathway. Inhibiting the secretion of RANTES may be one of the important immunosuppressive mechanisms of CsA.
引用
收藏
页码:546 / 548
相关论文
共 50 条
  • [21] RANDOMIZED PHASE II TRIAL OF COMBINATION IDIOTYPE VACCINE AND ANTI-CD3/ANTI-CD28 COSTIMULATED AUTOLOGOUS T CELLS IN PATIENTS WITH MULTIPLE MYELOMA POST-AUTOTRANSPLANTATION
    Qazilbash, Muzaffar
    Stadtmauer, Edward
    Baladandayuthapani, Veera
    Tross, Beryl
    Honhar, Medhavi
    Cha, Soungchul
    Kim, Kunhwa
    Rao, Sheetal
    Popescu, Michael
    Shah, Nina
    Bashir, Qaiser
    Patel, Krina
    Shpall, Elizabeth
    Weber, Donna
    Thomas, Sheeba
    Shah, Jatin
    Orlowski, Robert
    Kerr, Naseem
    Garfall, Alfred
    Cohen, Adam
    Dengel, Karen
    June, Carl
    Champlin, Richard
    Kwak, Larry
    EXPERIMENTAL HEMATOLOGY, 2017, 53 : S70 - S71
  • [22] Randomized Phase II Trial of Combination Idiotype Vaccine and Anti-CD3/Anti-CD28 Costimulated Autologous T Cells in Patients with Multiple Myeloma Post-Autotransplantation
    Qazilbash, Muzaffar H.
    Stadtmauer, Edward A.
    Baladandayuthapani, Veera
    Lin, Heather
    Tross, Beryl M.
    Honhar, Medhavi
    Cha, Soung-Chul
    Kim, Kunhwa
    Rao, Sheetal S.
    Popescu, Michael
    Shah, Nina
    Bashir, Qaiser
    Patel, Krina
    Shpall, Elizabeth J.
    Weber, Donna M.
    Thomas, Sheeba K.
    Shah, Jatin J.
    Orlowski, Robert Z.
    Kerr, Naseem D. S.
    Garfall, Alfred L.
    Cohen, Adam D.
    Dengel, Karen
    June, Carl H.
    Champlin, Richard E.
    Kwak, Larry
    BLOOD, 2016, 128 (22)
  • [23] Randomized Phase II Trial of Combination Idiotype Vaccine and Anti-CD3/Anti-CD28 Costimulated Autologous T Cells in Patients with Multiple Myeloma Post-Autotransplantation
    Qazilbash, Muzaffar
    Stadtmauer, Edward
    Baladandayuthapani, Veera
    Tross, Beryl
    Honhar, Medhavi
    Cha, Soung-chul
    Kim, Kunhwa
    Rao, Sheeta
    Popescu, Michael
    Shah, Nina
    Bashir, Qaiser
    Patel, Krina
    Shpall, Elizabeth
    Weber, Donna
    Thomas, Sheeba
    Shah, Jatin
    Orlowski, Robert
    Kerr, Naseem
    Garfall, Alfred
    Cohen, Adam
    Dengel, Karen
    June, Carl
    Champlin, Richard
    Kwak, Larry
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2017, 17 (01): : E138 - E139
  • [24] PARTIALLY PURIFIED HUMAN BCGF SYNERGIZES WITH AN ANTI-CD3 MAB TO INDUCE PROLIFERATION OF HUMAN LYMPHOCYTES-T
    MARTINEZ, O
    MARRA, MN
    GAROVOY, MR
    FEDERATION PROCEEDINGS, 1987, 46 (03) : 780 - 780
  • [25] Anti-CD3/anti-CD28 bead stimulation overcomes CD3 unresponsiveness in patients with head and neck squamous cell carcinoma
    Shibuya, TY
    Wei, WZ
    Zormeier, M
    Ensley, J
    Sakr, W
    Mathog, RH
    Meleca, RJ
    Yoo, GH
    June, CH
    Levine, BL
    Lum, LG
    ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY, 2000, 126 (04) : 473 - 479
  • [26] Effects of an FcγRIIA polymorphism on leukocyte gene expression and cytokine responses to anti-CD3 and anti-CD28 antibodies
    Michelle M. Stein
    Cara L. Hrusch
    Anne I. Sperling
    Carole Ober
    Genes & Immunity, 2019, 20 : 462 - 472
  • [27] Effects of an FcγRIIA polymorphism on leukocyte gene expression and cytokine responses to anti-CD3 and anti-CD28 antibodies
    Stein, Michelle M.
    Hrusch, Cara L.
    Sperling, Anne, I
    Ober, Carole
    GENES AND IMMUNITY, 2019, 20 (06) : 462 - 472
  • [28] Antitumor reactivity of anti-CD3/anti-CD28 bead activated lymphoid cells: Implications for cell therapy.
    Ito, F
    Carr, A
    Svensson, H
    Chang, A
    Qiao, L
    BLOOD, 2002, 100 (11) : 677A - 677A
  • [29] Single Cell Analysis of Blood Mononuclear Cells Stimulated Through Either LPS or Anti-CD3 and Anti-CD28
    Lawlor, Nathan
    Nehar-Belaid, Djamel
    Grassmann, Jessica D. S.
    Stoeckius, Marlon
    Smibert, Peter
    Stitzel, Michael L.
    Pascual, Virginia
    Banchereau, Jacques
    Williams, Adam
    Ucar, Duygu
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [30] COACTIVATION OF CD3+, CD4+, AND CD8+ CELLS WITH ANTI-CD3 + ANTI-CD28 INDUCES GROWTH AND CYTOTOXICITY FOR ADOPTIVE IMMUNOTHERAPY
    LUM, LG
    JOSHI, ID
    JUNE, C
    MARTILOTTI, F
    GALOFORO, S
    UBERTI, JP
    LEDBETTER, JA
    SENSENBRENNER, LL
    EXPERIMENTAL HEMATOLOGY, 1992, 20 (06) : 729 - 729